We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current RDY market cap is 10.6B. The company's latest EPS is INR and P/E is N/A.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Total Revenue | 72.15B | 70.83B | 75.4B | 81.49B | 83.59B |
| Operating Income | 17.4B | -35.65B | 17.97B | 18.11B | 18.76B |
| Net Income | 13.79B | 13.07B | 13.92B | 12.55B | 14.13B |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Total Revenue | 178.76B | 190.62B | 216.11B | 252.99B | 282.45B |
| Operating Income | 34.25B | 34.08B | 36.76B | 59.76B | 67.4B |
| Net Income | 20.26B | 19.52B | 21.83B | 45.07B | 55.78B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Total Assets | 0 | 387.52B | 415.3B | 465.96B | 0 |
| Total Liabilities | 0 | 106.97B | 120.67B | 156.67B | 0 |
| Total Equity | 0 | 280.55B | 294.63B | 309.28B | 0 |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Total Assets | 232.25B | 266.17B | 297.47B | 322.85B | 388.64B |
| Total Liabilities | 76.27B | 89.75B | 105.35B | 89.99B | 106.09B |
| Total Equity | 155.99B | 176.42B | 192.12B | 232.86B | 282.55B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Operating | N/A | 45.43B | 8.5B | 17.81B | N/A |
| Investing | N/A | -40.28B | -20.25B | -39.32B | N/A |
| Financing | N/A | -3.76B | 9.54B | 25.69B | N/A |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Operating | 29.84B | 35.7B | 28.11B | 58.88B | 45.43B |
| Investing | -4.92B | -22.66B | -26.39B | -41.37B | -40.28B |
| Financing | -25.16B | -298M | -2.42B | -26.86B | -3.76B |
| Market Cap | 10.6B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 834.39M |
| Average Volume (1 week) | 1.24M |
| Average Volume (1 Month) | 1.82M |
| 52 Week Change | -17.31% |
| 52 Week High | 16.892 |
| 52 Week Low | 12.62 |
| Spread (Intraday) | 0.01 (0.08%) |
| Company Name | Dr Reddys Laboratories Ltd |
| Address |
8-2-337, road no. 3, banjara hills hyderabad, andhra pradesh 500034 |
| Website | https://www.drreddys.com |
| Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
